The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit
CERRITOS, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virni
Market Cool On The Oncology Institute, Inc.'s (NASDAQ:TOI) Revenues Pushing Shares 29% Lower
Unfortunately for some shareholders, the The Oncology Institute, Inc. (NASDAQ:TOI) share price has dived 29% in the last thirty days, prolonging recent pain.
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersHelius Medical Tech (NASDAQ:HSDT) shares increased by 48.9% to $3.96 during Friday's pre-market session. The company's market cap stands at $3.5 million. Vaxxinity (NASDAQ:VAXX) shares moved up
The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call
PDF Version CERRITOS, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC ("TOI") (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today ann
Press Release: Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute
Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute Executive Brings Wealth of Experience in Advancing Value-Based Specialty Care Models CERRITOS, Calif., April 08, 202
Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute
PDF Version Executive Brings Wealth of Experience in Advancing Value-Based Specialty Care ModelsCERRITOS, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. and its affilia
The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California
PDF Version CERRITOS, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) and Healthly, a rapidly growing healthcare company with over 180 p
The Oncology Institute, Inc. (NASDAQ:TOI) Q4 2023 Earnings Call Transcript
Oncology Institute Full Year 2023 Earnings: US$0.92 Loss per Share (Vs US$0.001 Profit in FY 2022)
Earnings Call Summary | The Oncology Institute(TOI.US) Q4 2023 Earnings Conference
The following is a summary of the The Oncology Institute, Inc. (TOI) Q4 2023 Earnings Call Transcript:Financial Performance:The Oncology Institute reported a year-over-year revenue growth of 20% for Q
The Oncology Institute Q4 Loss Widens, Revenue Increases
The Oncology Institute (TOI) reported a Q4 loss late Wednesday of $0.21 per diluted share, compared with a loss of $0.16 a year earlier. GAAP EPS was not available on Capital IQ for comparison. Operat
The Oncology Institute GAAP EPS of -$0.21, Revenue of $86M Beats by $3.96M
Oncology Institute 4Q Loss/Shr 21c >TOI
Oncology Institute 4Q Loss/Shr 21c >TOI
GUIDANCE: (TOI) THE ONCOLOGY INSTITUTE Forecasts Fiscal Year 2024 Revenue Range $400M - $415M
04:09 PM EDT, 03/27/2024 (MT Newswires) -- GUIDANCE: (TOI) THE ONCOLOGY INSTITUTE Forecasts Fiscal Year 2024 Revenue Range $400M - $415M
Earnings Flash (TOI) THE ONCOLOGY INSTITUTE Posts Q4 Revenue $85.8M
04:09 PM EDT, 03/27/2024 (MT Newswires) -- Earnings Flash (TOI) THE ONCOLOGY INSTITUTE Posts Q4 Revenue $85.8M
Press Release: The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024
The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024 CERRITOS, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI
Earnings Scheduled For March 27, 2024
Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million. • REE Automotive (NASDAQ:REE) is estimated to repor
The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024
PDF Version CERRITOS, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) ("TOI" or the "Company"), one of the largest value-based community oncology groups in
Earnings Outlook For The Oncology Institute
The Oncology Institute (NASDAQ:TOI) is set to give its latest quarterly earnings report on Wednesday, 2024-03-27. Here's what investors need to know before the announcement.Analysts estimate that The
TOI and MaxHealth Enter Full-risk Oncology Care Agreement
The Oncology Institute, Inc. (NASDAQ: TOI), a prominent value-based oncology group, has forged a significant new partnership with MaxHealth, a leader in value-based primary care.
No Data